(Q45376166)

13 December 2017

title

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning? (English)

1 reference

13 December 2017

8

1 reference

13 December 2017

5

Eugènia Negredo

1 reference

13 December 2017

6

Núria Pérez-Alvarez

1 reference

13 December 2017

Jose A Muñoz-Moreno

1

0 references

Maite Garolera

object named as

Maite Garolera

series ordinal

9

0 references

José Moltó

object named as

José Moltó

series ordinal

7

0 references

Bonaventura Clotet Sala

series ordinal

10

object named as

Bonaventura Clotet

1 reference

13 December 2017

3

Anna Prats

1 reference

13 December 2017

2

Carmina R Fumaz

1 reference

13 December 2017

Maria J Ferrer

4

1 reference

13 December 2017

publication date

1 May 2010

1 reference

13 December 2017

published in

Journal of NeuroVirology

1 reference

13 December 2017

volume

16

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

208-218

1 reference

Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia

13 December 2017

cites work

1 reference

12 December 2020

Prevalence of cognitive disorders differs as a function of age in HIV virus infection

1 reference

12 December 2020

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

12 December 2020

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

1 reference

12 December 2020

Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects

1 reference

12 December 2020

Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system

1 reference

12 December 2020

Human immunodeficiency virus-1 RNA levels in cerebrospinal fluid exhibit a set point in clinically stable patients not receiving antiretroviral therapy.

1 reference

12 December 2020

Neuropsychological aspects of coinfection with HIV and hepatitis C virus

1 reference

12 December 2020

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

1 reference

12 December 2020

Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

1 reference

12 December 2020

CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

1 reference

12 December 2020

An immune control model for viral replication in the CNS during presymptomatic HIV infection.

1 reference

12 December 2020

CD4+ count-guided interruption of antiretroviral treatment

1 reference

12 December 2020

HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound

1 reference

12 December 2020

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

1 reference

12 December 2020

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial

1 reference

12 December 2020

Independent evolution of HIV type 1 in different brain regions

1 reference

12 December 2020

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

1 reference

12 December 2020

Cerebrovascular changes in the basal ganglia with HIV dementia

1 reference

12 December 2020

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

1 reference

12 December 2020

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

1 reference

12 December 2020

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

1 reference

12 December 2020

HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia

1 reference

12 December 2020

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

12 December 2020

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort

1 reference

12 December 2020

Norms for letter and category fluency: demographic corrections for age, education, and ethnicity

1 reference

12 December 2020

Viral rebound syndrome in two HIV-1-positive patients after structured treatment interruption

1 reference

12 December 2020

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

1 reference

12 December 2020

Altered hippocampal-prefrontal activation in HIV patients during episodic memory encoding

1 reference

12 December 2020

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

12 December 2020

A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.

1 reference

12 December 2020

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

1 reference

12 December 2020

Early antiretroviral treatment prevents the development of central nervous system abnormalities in simian immunodeficiency virus-infected rhesus monkeys

1 reference

12 December 2020

Is it smart to continue to study treatment interruptions?

1 reference

12 December 2020

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

1 reference

12 December 2020

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies

1 reference

12 December 2020

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders

1 reference

12 December 2020

Warning: antiretroviral treatment interruption could lead to an increased risk of HIV transmission

1 reference

12 December 2020

Nadir CD4 cell count predicts neurocognitive impairment in HIV-infected patients.

1 reference

12 December 2020

Prognostic factors of long-term CD4+count-guided interruption of antiretroviral treatment

1 reference

12 December 2020

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection

1 reference

12 December 2020

10.3109/13550281003767710

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1070985853

0 references

1 reference